News
-
-
PRESS RELEASE
DriX H-9 drone: Exail announces two new orders, one of which integrates aerial anti-drone capabilities
Exail announces signing of two contracts for its DriX H-9 surface drone, accelerating adoption of autonomous solutions in maritime defense and security. CUAS capability for countering air threats and SHOM order for seabed mapping highlight system's versatility and operational relevance -
PRESS RELEASE
Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
Newron Pharmaceuticals S.p.A. announces Phase III Clinical Trial initiation with Evenamide, a novel Schizophrenia treatment in Japan, led by EA Pharma, a subsidiary of Eisai -
-
-
-
-
-
-